C07D 403/08
Linked by a carbon chain containing alicyclic rings
Official title: linked by a carbon chain containing alicyclic rings
C07D403/08 (Linked by a carbon chain containing alicyclic rings) appears on 222 US grants and 318 published applications in this corpus.
Search patents in C07D- Granted patents
- 222
- Published applications
- 318
- Assignees
- 185
- Inventors
- 1,016
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 0 |
| 2002 | 3 | 1 |
| 2003 | 1 | 3 |
| 2004 | 2 | 4 |
| 2005 | 2 | 5 |
| 2006 | 3 | 8 |
| 2007 | 2 | 5 |
| 2008 | 3 | 6 |
| 2009 | 4 | 14 |
| 2010 | 9 | 14 |
| 2011 | 6 | 12 |
| 2012 | 14 | 10 |
| 2013 | 11 | 19 |
| 2014 | 11 | 18 |
| 2015 | 11 | 19 |
| 2016 | 11 | 20 |
| 2017 | 21 | 18 |
| 2018 | 19 | 18 |
| 2019 | 15 | 19 |
| 2020 | 12 | 18 |
| 2021 | 6 | 16 |
| 2022 | 11 | 11 |
| 2023 | 13 | 20 |
| 2024 | 12 | 20 |
| 2025 | 7 | 13 |
| 2026 | 7 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of manufacture and synthesis of fluorescent dye compounds and uses thereof7 Jul 2026US 12,673,940 B2On Target Laboratories, LLC
- 5-membered heteroaryl carboxamide compounds for treatment of HBV16 Jun 2026US 12,655,130 B2Assembly Biosciences, Inc.
- Dry powder composition for peroral administration21 Apr 2026US 12,605,341 B2Vicore Pharma AB
- Salt and crystal form of steroid derivative regulator31 Mar 2026US 12,590,118 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Organic material composition and applications thereof10 Mar 2026US 12,570,635 B2Ningbo Lumilan Advanced Materials Co., Ltd.
- 5-membered heteroaryl carboxamide compounds for treatment of hbv17 Sep 2026US 2026/0274823 A1Assembly Biosciences, Inc.
- Novel Compound, and Pharmaceutical Composition for Prevention or Treatment of Cancer or Tumors Comprising Same20 Aug 2026US 2026/0242360 A1Daewoong Pharmaceutical Co., Ltd.
- 4-((5-(3-(4-(pyridin-2-yl)cyclopentyl)-1h-pyrazol-3-yl)amino)-benzenesulfonamide derivatives and similar compounds as cdk inhibitors for the treatment of cancer16 Jul 2026US 2026/0200897 A1BeOne Medicines I GmbH
- Indole phthalocyanine compound, preparation method therefor, and use thereof in tumor diagnosis imaging9 Jul 2026US 2026/0191998 A1Asieris Pharmaceuticlals (Shanghai) Co., Ltd.
- Aryl-containing amine compound, preparation method therefor and use thereof25 Jun 2026US 2026/0174739 A1Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Most cited
By later US patents
- Complement pathway modulators and uses thereof90US 9,056,874 B2Novartis AG · 2015
- [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders55US 6,245,799 B1American Home Products Corporation · 2001
- Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents33US 8,030,488 B2Xenon Pharmaceuticals Inc. · 2011
- Substituted heteroaryl derivatives32US 8,138,187 B2Gruenenthal GmbH · 2012
- Ether compounds for treatment of complement mediated disorders30US 10,550,140 B2Achillion Pharmaceuticals, Inc. · 2020